Relation and Novartis collaborate to advance treatments for atopic diseases using AI and immuno-dermatology expertise. Relation receives $55 million upfront, with potential milestones up to $1.7 ...
The Swiss pharma group Novartis has entered a multi-program strategic collaboration with London-based biotech Relation Therapeutics to discover and develop novel treatments for atopic diseases such as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback